Folate Analog Metabolic Inhibitor [EPC]

430292 reported adverse events

Drugs of this class: METHOTREXATE PRALATREXATE PEMETREXED PEMETREXED DIPOTASSIUM

These side effects are most commonly reported by patients taking drugs of the Folate Analog Metabolic Inhibitor [EPC] class:

#	Side effect	Count
0	DRUG INEFFECTIVE	76003
1	RHEUMATOID ARTHRITIS	38029
2	ARTHRALGIA	36346
3	PAIN	35595
4	OFF LABEL USE	35054
5	FATIGUE	29827
6	NAUSEA	24976
7	JOINT SWELLING	22340
8	HEADACHE	21099
9	RASH	20480

See all common reactions for Folate Analog Metabolic Inhibitor [EPC]

Drugs of the Folate Analog Metabolic Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

#	Side effect	Count	Frequency
0	HUMAN ANTICHIMERIC ANTIBODY POSITIVE	291	0.8713
1	ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE	5673	0.8316
2	RHEUMATOID FACTOR POSITIVE	4426	0.7918
3	SWOLLEN JOINT COUNT INCREASED	2327	0.7885
4	ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY	507	0.7752
5	RHEUMATIC FEVER	3056	0.7378
6	PEMPHIGUS	8760	0.7334
7	RED BLOOD CELL SEDIMENTATION RATE ABNORMAL	1647	0.7236
8	LUPUS VULGARIS	745	0.6917
9	SYNOVITIS	12080	0.6895

See all enriched reactions for Folate Analog Metabolic Inhibitor [EPC]